Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies

标题
Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies
作者
关键词
-
出版物
CLINICAL CANCER RESEARCH
Volume 21, Issue 6, Pages 1267-1272
出版商
American Association for Cancer Research (AACR)
发表日期
2015-03-13
DOI
10.1158/1078-0432.ccr-14-2877

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now